Refresh
Gainers Losers Sectors Indices Forex Mutual Funds

Dr. Reddy's Laboratories Ltd.

Price on BSE   12 Aug,15:51 LIVE
1,198.95
-6.05
(-0.50%)

© 2026 Rediff.com
  • Volume :
  • 95,446.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.00 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.40 - 1,080.05
  • Mkt Cap (Rs. Cr) :
  • 100,076.36
Price on NSE   12 Aug,15:59 LIVE
1,200.00
-5.00
(-0.41%)

© 2026 Rediff.com
  • Volume :
  • 2,366,909.00
  • Prev Close :
  • 1,205.00
  • Day's H/L (Rs.) :
  • 1,206.80 - 1,190.00
  • 52wk H/L (Rs.) :
  • 1,414.90 - 1,101.00
  • Mkt Cap (Rs. Cr) :
  • 0.00

View more

Market News

Indian drugmakers in no rush to shift to US despite tariff threat
Rediff.com   1 day(s) ago
Dr Reddy's Labs plunges 69% to Rs 443 crore, hit by lenalidomide exit and semaglutide issues
Rediff.com   23 Jul 2026
Q1 Earnings, West Asia Tensions, Crude Oil to Drive Market Movement This Week
Rediff.com   19 Jul 2026
Indian Pharma Bets Beyond US Generics
Rediff.com   26 Jun 2026
Report Card - Dr. Reddy's Laboratories Ltd.
PE Ratios
31.25
EPS (Rs.)
38.56
Sales (Rs. Cr)
5,136.60
Face Value (Rs.)
1
Net Profit Margin(%)
15.68
Last Bonus
1:1
Last Dividend(%)
800
Return on Average Equity
10.26

News for Dr. Reddy's Laboratories Ltd.

Dr Reddy''s Launches Generic Sugammadex Injection in US
Dr Reddy''s launches generic Sugammadex injection in the US, offering an affordable alternative to Bridion for reversing muscle relaxants during surgery.
Aug 04, 2026 13:33
Dr Reddy''s shares tumble 9% post-Q1 earnings, hit 52-week low
Dr Reddy''s shares plunged nearly 9% to a 52-week low after Q1 net profit fell 69.2%. Semaglutide API issues and generics revenue dip cited.
Jul 23, 2026 11:00
Dr Reddy''s CEO: US Tariffs Will Hike Drug Prices
Dr Reddy''s CEO Erez Israeli warns US tariffs on generic medicines will lead to higher drug prices. India, a major exporter, will be impacted by Trump''s plan.
Jul 22, 2026 19:03
Dr Reddy''s Q1 Profit Plunges 69.2% Amid Semaglutide Issue
Dr Reddy''s Q1 net profit fell 69.2% to Rs 434.8 cr, impacted by semaglutide ingredient provisions & North America generics dip. Revenue also declined.
Jul 22, 2026 17:19
US Tariffs on Generic Drugs: India''s Pharma Exports at Risk
GTRI warns US tariffs on generic medicines could significantly impact India''s largest pharma export market. Trump''s plan aims to reshore production, affecting Indian companies.
Jul 22, 2026 14:24

More News for Dr. Reddy's Laboratories Ltd. »

About Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology. Wikipedia

News for Pharmaceuticals

Radisson Opens Park Inn Hotel in Bengaluru Whitefield
Radisson Hotel Group launches Park Inn by Radisson Bengaluru Whitefield, an 82-room hotel. Debuts in tech & commercial hub, boosting business travel.
Aug 12, 2026 15:49
Gautam Adani: US Case Dismissal Reinforces Faith in Rule of Law
Gautam Adani reflects on US case dismissal, stating adversity reinforced his faith in the rule of law. He discusses Hindenburg allegations & group''s focus on nation-building.
Aug 12, 2026 15:37
ChargeZone, Landmark Cars Partner for EV Charging in India
ChargeZone and Landmark Cars announce a strategic partnership to offer EV charging benefits to customers buying electric vehicles from Landmark dealerships across India.
Aug 12, 2026 14:38
Axis Bank Raises $300M via Bonds for Business Growth
Axis Bank successfully raised USD 300 million by issuing senior notes to overseas investors at a 5.348% coupon, listed on IFSC exchanges, to fund business growth.
Aug 12, 2026 14:13
Central Bank of India Mobilizes $250M via RBI FCNR(B) Window
Central Bank of India's CEO Kalyan Kumar announces $250M mobilized under RBI's FCNR(B) window, surpassing targets to boost foreign capital inflows.
Aug 12, 2026 13:52

More News »

Top News

MP Govt Bans Analogue Paneer, Promotes Natural Paneer
Madhya Pradesh government bans analogue paneer due to health concerns. CM Mohan Yadav promotes natural paneer & milk products, boosting state''s identity.
Aug 12, 2026 15:54
Radisson Opens Park Inn Hotel in Bengaluru Whitefield
Radisson Hotel Group launches Park Inn by Radisson Bengaluru Whitefield, an 82-room hotel. Debuts in tech & commercial hub, boosting business travel.
Aug 12, 2026 15:49
Aries Agro Q1 Profit Jumps to Rs 14.84 Cr on Higher Sales
Aries Agro Ltd. announced a significant profit increase to Rs 14.84 crore in Q1 2026-27, up from Rs 9.93 crore, driven by 16% higher revenue. Rahul Mirchandani re-appointed MD.
Aug 12, 2026 15:45
TPCI Establishes Committee to Grow India''s Pet Food Market
TPCI launches a national committee to drive growth & innovation in India''s rapidly expanding pet food industry. Addresses policy, trade, & sustainable framework for pet health.
Aug 12, 2026 15:43
Delhi HC Halts SC/HC Judges'' IT Returns on Tax Exemption
Delhi High Court orders IT dept to halt processing of Supreme Court & High Court judges'' tax returns amid a dispute over allowance exemptions under the new tax regime.
Aug 12, 2026 15:40

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2026 Rediff.com